valacyclovir
Generic: valacyclovir
Labeler: bryant ranch prepackDrug Facts
Product Profile
Brand Name
valacyclovir
Generic Name
valacyclovir
Labeler
bryant ranch prepack
Dosage Form
TABLET
Routes
Active Ingredients
valacyclovir hydrochloride 500 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71335-2566
Product ID
71335-2566_20567a71-8bfc-47d2-922b-4ff642aba801
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209553
Listing Expiration
2026-12-31
Marketing Start
2023-02-14
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
713352566
Hyphenated Format
71335-2566
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
valacyclovir (source: ndc)
Generic Name
valacyclovir (source: ndc)
Application Number
ANDA209553 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/1
Packaging
- 60 TABLET in 1 BOTTLE (71335-2566-0)
- 15 TABLET in 1 BOTTLE (71335-2566-1)
- 10 TABLET in 1 BOTTLE (71335-2566-2)
- 4 TABLET in 1 BOTTLE (71335-2566-3)
- 7 TABLET in 1 BOTTLE (71335-2566-4)
- 20 TABLET in 1 BOTTLE (71335-2566-5)
- 30 TABLET in 1 BOTTLE (71335-2566-6)
- 8 TABLET in 1 BOTTLE (71335-2566-7)
- 90 TABLET in 1 BOTTLE (71335-2566-8)
- 14 TABLET in 1 BOTTLE (71335-2566-9)
Packages (10)
71335-2566-0
60 TABLET in 1 BOTTLE (71335-2566-0)
71335-2566-1
15 TABLET in 1 BOTTLE (71335-2566-1)
71335-2566-2
10 TABLET in 1 BOTTLE (71335-2566-2)
71335-2566-3
4 TABLET in 1 BOTTLE (71335-2566-3)
71335-2566-4
7 TABLET in 1 BOTTLE (71335-2566-4)
71335-2566-5
20 TABLET in 1 BOTTLE (71335-2566-5)
71335-2566-6
30 TABLET in 1 BOTTLE (71335-2566-6)
71335-2566-7
8 TABLET in 1 BOTTLE (71335-2566-7)
71335-2566-8
90 TABLET in 1 BOTTLE (71335-2566-8)
71335-2566-9
14 TABLET in 1 BOTTLE (71335-2566-9)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "20567a71-8bfc-47d2-922b-4ff642aba801", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["65d13d0e-cf7f-4422-81f1-3dfce4722718"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-2566-0)", "package_ndc": "71335-2566-0", "marketing_start_date": "20250205"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (71335-2566-1)", "package_ndc": "71335-2566-1", "marketing_start_date": "20250205"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (71335-2566-2)", "package_ndc": "71335-2566-2", "marketing_start_date": "20250205"}, {"sample": false, "description": "4 TABLET in 1 BOTTLE (71335-2566-3)", "package_ndc": "71335-2566-3", "marketing_start_date": "20250205"}, {"sample": false, "description": "7 TABLET in 1 BOTTLE (71335-2566-4)", "package_ndc": "71335-2566-4", "marketing_start_date": "20250205"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (71335-2566-5)", "package_ndc": "71335-2566-5", "marketing_start_date": "20250205"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-2566-6)", "package_ndc": "71335-2566-6", "marketing_start_date": "20250205"}, {"sample": false, "description": "8 TABLET in 1 BOTTLE (71335-2566-7)", "package_ndc": "71335-2566-7", "marketing_start_date": "20250205"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-2566-8)", "package_ndc": "71335-2566-8", "marketing_start_date": "20250205"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (71335-2566-9)", "package_ndc": "71335-2566-9", "marketing_start_date": "20250205"}], "brand_name": "Valacyclovir", "product_id": "71335-2566_20567a71-8bfc-47d2-922b-4ff642aba801", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71335-2566", "generic_name": "Valacyclovir", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20230214", "listing_expiration_date": "20261231"}